Search

Your search keyword '"Manochehri, F"' showing total 3 results
Start Over Author "Manochehri, F"
3 results on '"Manochehri, F"'

2. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization

Author

Colella, G, Bottelli, R, De Carlis, L, Sansalone, C, Rondinara, G, Alberti, A, Belli, L, Gelosa, F, Iamoni, G, Rampoldi, A, De Gasperi, A, Corti, A, Mazza, E, Aseni, P, Meroni, A, Slim, A, Finzi, M, Di Benedetto, F, Manochehri, F, Follini, M, Ideo, G, Forti, D, Sansalone, CV, Rondinara, GF, Belli, LS, Iamoni, GM, Slim, AO, Follini, ML, Colella, G, Bottelli, R, De Carlis, L, Sansalone, C, Rondinara, G, Alberti, A, Belli, L, Gelosa, F, Iamoni, G, Rampoldi, A, De Gasperi, A, Corti, A, Mazza, E, Aseni, P, Meroni, A, Slim, A, Finzi, M, Di Benedetto, F, Manochehri, F, Follini, M, Ideo, G, Forti, D, Sansalone, CV, Rondinara, GF, Belli, LS, Iamoni, GM, Slim, AO, and Follini, ML

Abstract

Between January 1989 and June 1997, 533 patients (423 male, 110 female, mean age 61 years, range 22-89 years) with hepatocellular carcinoma (HCC) were observed at our center. We report on 419 patients retrospectively compared for different treatments: liver transplantation (LT; 55 patients), resective surgery (RS; 41 patients), transarterial chemoembolization (TACE; 171 patients) and percutaneous ethanol injection (PEI; 152 patients). The 3- and 5-year actuarial survival rates were, respectively, 72% and 68% for LT, 64 and 44% for RS, 54 and 36% for PEI, and 32 and 22% for TACE. Survival curves were compared for sex, age, tumor characteristics, alphafetoprotein level, Child class, and etiology of cirrhosis. All patient-related characteristics examined (sex, age) are not significantly related to patient survival. Tumor-related variables and associated liver disease variables significantly conditioned survival in relation to different treatments. LT seems to be the treatment of choice for monofocal HCC less then 5 cm in diameter and in selected cases of plurifocal HCC. © Springer-Verlag 1998

Published
1998

3. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization

Author

R. Bottelli, A. De Gasperi, A. Meroni, M. Finzi, L De Carlis, G. M. Iamoni, Abdallah Slim, F. Manochehri, F. Di Benedetto, Luca S. Belli, Domenico Forti, G. Colella, Gianfranco Rondinara, F. Gelosa, Paolo Aseni, M.L. Follini, Antonio Rampoldi, Antonino Alberti, A. Corti, C. V. Sansalone, E. Mazza, Gaetano Ideo, Colella, G, Bottelli, R, De Carlis, L, Sansalone, C, Rondinara, G, Alberti, A, Belli, L, Gelosa, F, Iamoni, G, Rampoldi, A, De Gasperi, A, Corti, A, Mazza, E, Aseni, P, Meroni, A, Slim, A, Finzi, M, Di Benedetto, F, Manochehri, F, Follini, M, Ideo, G, and Forti, D

Subjects
Adult, Male, medicine.medical_specialty, Carcinoma, Hepatocellular, Cirrhosis, Hepatocellular carcinoma, medicine.medical_treatment, Liver transplantation, Transarterial chemoembolization, Gastroenterology, Injections, Liver disease, Actuarial Analysis, Aged, 80 and over, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Ethanol, Female, Hepatectomy, Humans, Liver Neoplasms, Liver Transplantation, Middle Aged, Retrospective Studies, Survival Rate, Internal medicine, medicine, Chemoembolization, Therapeutic, Liver surgery, Survival rate, Aged, 80 and over, Transplantation, business.industry, medicine.disease, Surgery, Percutaneous ethanol injection, business
Abstract

Between January 1989 and June 1997, 533 patients (423 male, 110 female, mean age 61 years, range 22-89 years) with hepatocellular carcinoma (HCC) were observed at our center. We report on 419 patients retrospectively compared for different treatments: liver transplantation (LT; 55 patients), resective surgery (RS; 41 patients), transarterial chemoembolization (TACE; 171 patients) and percutaneous ethanol injection (PEI; 152 patients). The 3- and 5-year actuarial survival rates were, respectively, 72% and 68% for LT, 64 and 44% for RS, 54 and 36% for PEI, and 32 and 22% for TACE. Survival curves were compared for sex, age, tumor characteristics, alphafetoprotein level, Child class, and etiology of cirrhosis. All patient-related characteristics examined (sex, age) are not significantly related to patient survival. Tumor-related variables and associated liver disease variables significantly conditioned survival in relation to different treatments. LT seems to be the treatment of choice for monofocal HCC less then 5 cm in diameter and in selected cases of plurifocal HCC. © Springer-Verlag 1998

Catalog

Books, media, physical & digital resources
See catalog results